LionBird

Congratulations to the Assured Allies team on closing this $42.5M Series B! We're proud to have backed this team since its early days and couldn't be more excited about all they've accomplished.

Read more via TechCrunch:

Assured Allies secures $42.5M Series B to help Americans ‘successfully age’ The company uses machine learning, predictive analytics and science-of-aging to offer retirement products and programs.

Congratulations Nerivio by Theranica on receiving approval for the Nerivio prescription wearable as a dual-use acute and preventive treatment for !

Read more:

Theranica receives FDA approval for Nerivio to prevent migraines Theranica has secured clearance from the FDA for its Nerivio prescription wearable as a dual-use acute and preventive treatment of migraine.

Exciting partnership between Rhino Health and NTT DATA will provide clinical researchers and AI developers with access to healthcare data at scale. Very proud to back the Rhino team and thrilled with this progress!

Read more:

Rhino Health and NTT DATA Collaborate to Build Federated Network for Unlocking Siloed Healthcare Data BOSTON, MA / ACCESSWIRE / January 30, 2023 / Rhino Health, a healthcare AI company, and NTT DATA announce a collaboration to provide clinical researchers and AI developers with access to healthcare data at scale. The collaboration addresses increasing demands for AI in imaging services and imaging b...

Thrilled to support the Nest Genomics team in its journey to make the world of genetic testing an integral part of everyday clinical care!

Find out how these veteran entrepreneurs in the genetic testing domain are building a data-driven, engaging product for healthcare providers to launch and scale genomic programs, via MedCity News:

Nest Genomics Raises $8.5M to Increase Access to Patients’ Genetic Information Nest Genomics just closed a $8.5 million seed financing round. The company provides the software infrastructure needed for health systems, clinics, drugmakers and payers to launch and scale genomic programs. It also provides tools for patients to easily access their genetic information.

Amazing results from Nerivio by Theranica's most recent study show users experienced an average reduction of 4 migraine days/month, with a reduction of 3.5 days/month in patients using other preventive migraine treatments and medications.

Read more via FierceBiotech: https://www.fiercebiotech.com/medtech/theranica-aims-stretch-fda-nod-study-neuromodulation-device-preventive-migraine-treatment

Theranica aims to stretch FDA nod with study of neuromodulation device as preventive migraine treatment Less than two years after the FDA cleared Theranica Bio-Electronics’ Nerivio neuromodulation armband as an acute migraine treatment in 2019, the company successfully lobbied the agency to expand it | Theranica is once again asking the FDA to expand its neuromodulation device's approved usage, posi...

Proud to back this incredible team - congratulations on closing this round!

Read about how Phantom Neuro is bridging the gap between available technology and limb injury patients' expected outcomes via The Wall Street Journal:

Investors Back Startup Aiming to Help Amputees Better Control Prosthetic Limbs Phantom Neuro secures $6 million in new seed financing for system using implantable sensors and artificial intelligence

What principles of entrepreneurial leadership apply to clinical medicine and vice versa?

LionBird partner Robert Lord catches up with host Shiv Gaglani to discuss this topic and many more in this recent podcast episode from Osmosis.

Listen here: https://www.osmosis.org/raisethelinepodcast/entrepreneurial-approach-to-medicine-dr-robert-lord

An Entrepreneurial-Minded Approach to Medicine - Dr. Robert Lord, Partner at LionBird Ventures | Osmosis Raise the Line “So much of healthcare actually does have parallels to the business world, insofar as much of our job is to help align people to the next steps that are in their best interest,” Dr. Robert Lord tells host Shiv Gaglani. Dr. Lord, who recently completed his medical degree at Johns Hopkins, underst...

Very excited to welcome Peter Pronovost, MD, PhD, FCCM - world leader in patient safety & clinical innovation - as senior advisor in the , our network of proven executives and entrepreneurs who have partnered with LionBird in the past and are available to help the next generation of digital health leaders.

Read more about Dr. Pronovost and the LionBird Rings community:

Dr. Peter Pronovost joins the LionBird Rings community /PRNewswire/ -- LionBird, a venture capital firm based in Israel and the U.S. investing in pre-scale digital health companies, today announced that Peter...

Thrilled to unveil our partnership with Assuta Ashdod Medical Center which will enhance links between Assuta's network of world-class clinicians and the digital health startup ecosystem in Israel.

There is incredible talent flow from Israel into digital health, but these founders face a challenge in navigating the complex US healthcare market. The LionBird Assuta Physician Ring will better enable these teams to make meaningful, early connections with the right industry experts.

Also proud to showcase a panel with some of the great founders backed by LionBird - Yoni Shtein, Moran Snir & Yuval Baror. It has been a privilege to watch these founders in the early stages of their journeys and we're excited about what's to come.

To learn more about LionBird Rings, visit: https://medium.com/lionbird/why-lionbird-rings-b408f38ef60

Excited to announce the final closing of LionBird's third fund, LionBird III, an $85 million digital health-focused fund with participation from strategic investors Healthcare of Ontario Pension Plan - HOOPP and TELUS.

At LionBird, we see healthcare teams working harder than ever with little improvement in outcomes, access, or cost savings – far from the promise that digital health should deliver. That's why our portfolio founders are paving the way for the next era in healthcare technology; realigning the work of innovation to the patients and providers who need it most.

With the closing of LionBird III, we believe we are more equipped than ever to help these exceptional founders lay the best foundations for their companies to scale and succeed.

Read more:

LionBird closes $85 million digital health-focused fund /PRNewswire/ -- LionBird, a venture capital firm based in Israel and the U.S. investing in pre-scale digital health companies, today announced the closing of...

Great overview of Phantom Neuro's AI-powered, low risk, high accuracy system for lifelike control of robotic orthopedic technologies! We're proud to have led this $3.3M seed round and offer our support to this impressive team in improving quality of life for prosthetic limb patients by bridging the gap between available tech and patient expectations.

Read more about Phantom's technology and its expert founder, Connor Glass, via Erin RW Brodwin at Axios: https://www.axios.com/phantom-neuro-raises-33m-169a087b-152f-4a9e-8867-64b15fed7e69.html

Phantom Neuro is building a system to help people control robotic limbs. The startup's tech is based out of Johns Hopkins.

Thrilled to congratulate Maverick Medical AI on closing its $5 million Seed round, co-led by LionBird. This impressive team has developed an platform, mCoder, that addresses the challenges of medical coding efficiency, accuracy, and capacity.

We're excited about the opportunity to support this team throughout their journey and can't wait to see what's to come for Maverick.

Read more via Calcalist כלכליסט: https://www.calcalistech.com/ctechnews/article/bj55xrpw5

Maverick Medical closes $5 million Seed round for AI medical coding platform | Ctech The Israeli startup has developed an AI platform, mCoder, that addresses the challenges of medical coding efficiency, accuracy, and capacity

Proud to announce the U.S. Food and Drug Administration has granted clearance for 's digital therapeutic mobile app, - the first ever -authorized treatment specifically for abdominal pain associated with in adults.

metaMe's cutting edge technology provides patients with remote behavioral therapy based on gut-directed (GDH). Until now, GDH has only been available in-person with licensed therapists - metaMe's Regulora is making this proven drug-free therapy accessible to the millions of Americans struggling with IBS.

Congratulations to the team on this exciting milestone!

Read more: https://www.prweb.com/releases/metame_health_receives_fda_clearance_for_regulora_the_first_fda_authorized_treatment_specifically_for_abdominal_pain_due_to_irritable_bowel_syndrome_ibs/prweb18363959.htm

metaMe Health Receives FDA Clearance for Regulora®, the First FDA-authorized Treatment Specifically for Abdominal Pain Due to Irritable Bowel Syndrome (IBS) CHICAGO (PRWEB) November 30, 2021 -- Abdominal pain is the primary symptom of all IBS subtypes (IBS-C, IBS-D, and IBS-M), and is the number one reason patients seek treatment for their IBS. Regulora® is a prescription Digital Therapeutic (PDT) that is self-administered through an Apple or Android s...

Thrilled to welcome TELUS Ventures as a strategic digital health limited partner in our third fund, LionBird III.

With TELUS's rich portfolio of digital health solutions and go-to-market channels, we'll be able to strengthen our value proposition of helping startups to navigate the complex healthcare market and connect with the right stakeholders early on.

We're very excited about this partnership and look forward to collaborating with the TELUS Ventures team!



https://lionbird.com/lionbird-adds-strategic-digital-health-lp-for-its-third-fund/

» LionBird adds strategic digital health LP for its third fund Company announces TELUS Ventures as investor in LionBird III TEL AVIV – October 18, 2021 – LionBird, a venture capital firm based in Tel Aviv and Chicago, investing in pre-scale digital health companies, today announced TELUS Ventures as a strategic limited partner in its third fund, LionBird I....

Excited to congratulate Laguna Health on the launch of its digital care app for post-hospital recovery. In its clinical trial with NorthShore University HealthSystem, they're seeing an 80% reduction in readmissions with app-engaged patients.

Read more via MedCity News: https://medcitynews.com/2021/09/northshore-university-health-system-to-test-laguna-healths-new-post-discharge-recovery-app/

NorthShore University HealthSystem to test Laguna Health’s new post-discharge recovery app The app provides users with a personalized recovery plan, education materials and virtual access to a care team that includes behavioral health specialists. The NorthShore system will conduct a clinical trial to test the app after which it will decide whether to deploy the solution across its hospit...

Congratulations Ovia Health on joining Labcorp (marking our second LionBird I acquisition today)! We first partnered with this impressive team in 2013, and we couldn't be more proud of Ovia's tremendous growth since then - supporting more than 15 million families to date.

Read more: https://www.businesswire.com/news/home/20210812005858/en/Labcorp-Extends-Leadership-in-Women%E2%80%99s-Health-With-Acquisition-of-Ovia-Health

Labcorp Extends Leadership in Women’s Health With Acquisition of Ovia Health Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has acquired Ovia Health, a digital health platform used by millio

Thrilled to congratulate Bento for Business on its acquisition by U.S. Bank! As a partner from the beginning, we've had the privilege of watching Bento's tremendous growth unfold, and we're so proud of all this team has accomplished.

Read more via PYMNTS.com: What's Next in Payments: https://www.pymnts.com/news/partnerships-acquisitions/2021/us-bank-to-buy-biz-expense-management-platform-bento-technologies/

US Bank to Buy Bento Technologies U.S. Bank has agreed to purchase FinTech company Bento Technologies, according to a Thursday (Aug. 12) company announcement.

Through this integration with by , Tytocare is enabling health organizations to drive better care through easier access and a more informed care pathway for each patient.

Read more about this exciting partnership via FierceHealthIT: https://www.fiercehealthcare.com/digital-health/tytocare-teams-up-epic-to-integrate-remote-monitoring-data-into-patients-records

TytoCare teams up with Epic to integrate remote monitoring data into patients' records As part of the digital health boom, healthcare providers want to better integrate data from devices and remote patient monitoring platforms into patients' health records. TytoCare, the maker of an at-home medical exam and telehealth device kit, is stepping up its partnership with electronic health r...

Congratulations on closing this $20M round! Read about how this -driven is helping people get healthier through increased compliance, via TechCrunch:

https://techcrunch.com/2021/07/19/switch-raises-20m-for-a-personalized-engagement-system-designed-to-boost-health-outcomes/

Sweetch raises $20M for a personalized engagement system designed to boost health outcomes – TechCrunch You’ve just sat down to dinner and your wearable device reminds you to get up and get in your steps for the day. Maybe the app has a point, but odds are you’ll push the notification to the side. The founders of Sweetch, an Israeli company creating its own AI-driven behavior change app, are betti...

We're so proud to have given our support to this innovative team from its early days! With this $18.3M , Assured Allies will radically reset expectations for successful . Read more about Assured and this new funding via MobiHealthNews:

https://www.mobihealthnews.com/news/assured-allies-scores-185m-help-help-seniors-navigate-aging-process

Assured Allies scores $18.3M to help seniors navigate the aging process The Boston and Tel Aviv-based company includes a predictive analytics tool which helps intervene in a person's aging trajectory.

LionBird Partner Jonathan Friedman sharing his thoughts on which business models work in digital health to the latest cohort of SpearHealth

Excited to congratulate Protenus CEO Nick Culbertson on being named a finalist by EY for the Entrepreneur Of The Year 2021 Mid-Atlantic Award! Well-deserved recognition for this visionary leader.
https://www.protenus.com/resources/ey-announces-nick-culbertson-as-entrepeneur-of-the-year-2021-mid-atlantic-finalist

EY Announces Nick Culbertson of Protenus as an Entrepreneur Of The Year® 2021 Mid-Atlantic Award Finalist Nick Culbertson is a Entrepreneur Of The Year® 2021 Mid-Atlantic Award Finalist

Thrilled to give our continued support to Protenus in this $21M Series D funding round and excited to welcome new investors MemorialCare Innovation Fund and Gaingels. We're so proud of all this team has accomplished and we're looking forward to what's next!

https://www.protenus.com/resources/protenus-raises-series-d

Protenus Raises Series D After Doubling Revenue While Reducing Risk for Health Systems MemorialCare Innovation Fund joins Protenus current investors in the $21M round

Congratulations Nerivio by Theranica on being named a silver winner of the 2021 Medical Design Excellence Awards in the Products/Mobile Medical Apps category. Proud to support this impressive team in providing non-invasive, treatment!



https://finance.yahoo.com/news/nerivio-wins-2021-medical-design-120000960.html

Nerivio® Wins 2021 Medical Design Excellence Award Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, today announced that its FDA-approved acute migraine treatment wearable Nerivio® has been named a silver winner of the 2021 Medical Design Excellence Awards (MDEA) in th...

Thrilled to congratulate on its public launch! Read the story firsthand from CEO Yoni Shtein, who sat down with Crunchbase to discuss the company's $6.6M funding and how this impressive team is ensuring successful post-hospital recovery:

https://news.crunchbase.com/news/laguna-health-tackles-post-hospital-recovery-with-6-6m-seed/

Laguna Health Tackles Post-Hospital Recovery With $6.6M Seed Laguna Health aims to reduce costly readmissions and shorten recovery times.

Thrilled to give our continued support to Nimble's impressive team. Within three weeks of launching their Kickstarter campaign, Nimble has received more than 4500 pre-orders, totaling almost $1.5 million - we're proud to partner with this team to help meet this tremendous consumer demand!

Read more via Calcalist כלכליסט: https://www.calcalistech.com/ctech/articles/0,7340,L-3907398,00.html

Nail-painting robot startup Nimble nets $10 million in seed funding Nimble, the world’s first device that uses artificial intelligence to self-paint and dry nails in 10 minutes per hand, also launched a Kickstarter campaign last month which has raised over $1.4 million

"To improve the global impact of AI tools and create equity in the standard of care, health care researchers and AI developers worldwide need to incorporate more diverse data that represent the range of people who are likely to benefit from advanced AI-based diagnostics and treatment pathways."

Read about how is accelerating in this STAT "First Opinion" piece co-authored by Rhino Health's CEO Ittai Dayan MD, Fiona Gilbert MD (Cambridge University Hospitals NHS Foundation Trust), and Mona G. Flores MD (NVIDIA).



https://www.statnews.com/2021/04/30/federated-learning-improve-data-diversity/?

Federated learning can help improve data diversity for health care - STAT Federated learning — applying AI to local data instead of shipping data to the cloud for analysis — can improve data diversity and AI models.

Excited to announce the collaboration of and Janssen Global to deploy across multiple therapeutic areas, helping accelerate the development of new, more effective & individualized treatments for patients.

Read more via FierceBiotech: https://www.fiercebiotech.com/medtech/janssen-licenses-physiq-s-ai-analytics-platform-to-make-data-collected-by-wearable-sensors

Janssen taps PhysIQ's AI platform to make wearable sensor data more useful By licensing PhysIQ's technology, Janssen will be able to expand its use of biosensors in—and therefore collect more data from—its clinical studies.

Thrilled to announce has closed its $100M to continue exploring more effective treatment and revolutionizing the approach to .

Read more about C2i's story from CEO & co-founder Asaf Zviran via TechCrunch:

https://techcrunch.com/2021/04/15/c2i-a-genomics-saas-product-to-detect-traces-of-cancer-raises-100m-series-b/

C2i, a genomics SaaS product to detect traces of cancer, raises $100M Series B – TechCrunch If you or a loved one has ever undergone a tumor removal as part of cancer treatment, you’re likely familiar with the period of uncertainty and fear that follows. Will the cancer return, and if so, will the doctors catch it at an early enough stage? C2i Genomics has developed software that’s 100...